anil potti physician former duke university associate professor cancer researcher focusing oncogenomics along joseph nevins center research fabrication scandal duke november office research integrity ori found potti engaged research according pottis voluntary settlement agreement ori potti continue perform research requirement supervision year neither admits denies oris findings research potti employed cancer center north research publications retracted one publication received expression concern two others anil potti graduated christian medical college vellore india finished internship internal medicine university north dakota school medicine potti completed training hematology oncology duke potti resigned duke following discovery flaws genomics research conducted duke allegations embellishments resume assuming responsibility anomalies scientific following resignation duke potti worked oncologist south carolina let go according office research integrity ori potti engaged scientific cancer researcher duke universitys medical center school medicine resigned november duke put administrative leave terminated clinical trials based research retracted published potti team accused falsifying data regarding use microarray genetic analysis personalised cancer treatment published various prestigious scientific journals questions concerning pottis work beginning notably two bioinformatic statisticians keith baggerly kevin coombes md anderson cancer brought widespread scrutiny discovered paul goldberg reported cancer potti claimed curriculum vitae rhodes scholar australian said referring association rhodes scholars australia award granted organisation former rhodes scholars bring commonwealth citizens attend overseas institutions pottis fraudulent research funded us government national institutes health national heart lung blood institute national cancer institute form six multiyear howard hughes medical minutes described case one biggest medical research frauds duke university became aware suspicions research misconduct medical student working potti nevins withdrew name research submitted memorandum entitled research concerns administration administration denied misconduct convinced student report experiences funding agency howard hughes medical institute duke later falsely claimed whistleblower involved potti scandal prompted institute medicine conduct study proper use genomics clinical institute medicines report entitled evolution translational omics lessons learned path forward published march made detailed specific recommendations clinical trials incorporate february joseph nevins stated abundantly clear manipulated data could occurred confirmed ori healthcare companies cut ties potti evidence surfaced potti fabricated awards resume american cancer society stopped payments fiveyear grant totaled potti received grant based duke university later reimbursed american cancer society full amount three clinical trials duke university medical center based pottis research came scrutiny temporarily suspended permanently stopped united states food drug administration usfda reviewed one studies several years initiation concluded study would require investigational new drug application fda audit showed investigational device exemption application filed otherwise found significant deficiencies dukes irb pottis medical license record north carolina medical board shows eleven settlements least incidents appear related late north carolina medical board reprimanded retains medical license board issued disciplinary action potti imposed sanctions consent order north carolina medical board stated board evidence could conclude potti received funding medical research result inaccuracies would otherwise received concluded pottis conduct described herein constitutes unprofessional separate action pottis medical license north carolina medical board reviewed payments made settle malpractice claims posted website public action warranted potti issued medical license missouri february march missouri medical board known board registration healing arts issued reprimand basis actions taken north carolina medical january potti applied medical license south carolina approved april potti employed practicing physician coastal cancer loris march february let addition settlements two lawsuits also filed potti well duke medical personnel charging medical negligence among response lawsuits potti stated aware false improper data included research robert califf duke testified looked pottis publications twothirds would retracted whole part science reported fallout duke case includes papers duke expects partially completely retracted february ten scientific papers authored potti others leaving duke potti hired online reputation manager reputation management company improve search results february wordpress received dmca takedown notices retraction watch blog posts critical potti posts removed retraction watch alleges dmca takedown notices based false november automattic provider wordpress webhost service hosts retraction watch filed suit filer takedown notice saying made false claims violation following questions raised genomics research led potti nevins duke national cancer institute requested institute medicine iom establish committee recommend ways strengthen omicsbased test development evaluation ioms recommendations released march spoke many parties responsible discovery development omicsbased tests including investigators institutions sponsors research fda report identified best practices enhance development evaluation translation omicsbased tests simultaneously reinforcing steps ensure tests appropriately assessed scientific validity used guide patient treatment clinical ioms recommendations aimed ensure progress omics test development grounded sound scientific practice reproducible resulting improved health care also continued public iom report added failure many parties duke detect act problems key data computational methods led inappropriate enrollment patients clinical trials premature launch companies retraction dozens research report specifically called scientific investigators make data computer codes computational procedures used develop clinical tests publicly accessible independent review ensure data research steps presented report also found socalled omics tests genomics proteomics diagnostic tools based molecular patterns general highly prone errors iom committee chair gilbert omenn computational biologist university michigan said problems could avoided noted well kinds problems unique duke lot lessons surely apply places omenn said one question neither duke people involved research able explicitly answer thus far data corruption manipulation would require thorough knowledge microarray data warehouse large specialised databases well bioinformatics occurred robert califfs comments addresses data provenance adequate quantitative collaboration accountability open dialogue issues beyond individual lab systems deal conflict interest curt exchange committee member thomas fleming professor biostatistics university washington joseph nevins refused say believed data problems occurred fleming pointed problems data improved experimental results seemed introduced intentionally cant address nevins responded cant get position speculating papers coauthored potti retracted seven others pottis retracted papers article published pnas gene expressions could allow researchers see tumors uniform throughout could also used colon cancer also help predict person respond treatment improve authors said wanted retract article unable reproduce certain key experiments described paper regarding validation use colon cancer prognostic signature includes validation performed dataset reported fig well generation prognostic scores colon cancer cell lines reported fig article published lancet oncology study involved patients oestrogenreceptornegative breast cancer researchers wanted confirm previous studies geneexpression signatures predicting effects chemotherapeutic article retracted validity results beginning questioned predictions made nature medicine article article published nature medicine gene expression signatures developed vitro drug sensitivity data affymetrix microarray data used help predict response sensitivity chemotherapeutic drugs well corresponding article retracted corrected many key experiments could article published jama journal american medicine association patients earlystage breast carcinoma studys main point find gene expression signatures could refine breast cancer prognosis article talks cancer genomic technology chemotherapy article retracted large part article based another article potti written published nature medicine article nature medicine retracted failure reproduce article published journal clinical oncology usually platinumbased chemotherapy used treat nonsmall cell lung cancer patients respond highly variable article also talks predicting individuals respond cisplatin article retracted experiments could article published journal blood venous thromboembolism vte affects americans three aplas study consisted patients aps vte vte without apla apla healthy geneexpression profiles identify predict individuals aps patients vte without apla important able predict aps venous thrombosis help management article retracted authors unable reproduce data potti article published new england journal medicine patients study stage ib ii iiia nonsmall cell lung cancer many patients receive surgery risk relapse high others receive toxic chemotherapy unnecessarily study used geneexpressions evaluate form treatment would article retracted authors could reproduce results article published plos one important cancer patients receive effective treatment also hopefully best quality life possible researchers developed mrna microrna profiles tested mrna profiles breast cancer patients breast cancer patients treated tfac chemotherapy article retracted information used derived nature medicine article retracted article retracted felt article paper published journal clinical oncology february research studied ovarian cancer patient responses platinumbased therapy marks latest series expected potti retractions another expected partial paper published clinical cancer research december study purportedly found common gene expression pattern lung adenocarcinomas normal human embryonic stem cells associated shorter survival patients lung february manuscript retraction statement signed authors indicated clinical information data set available time signature development incorrect statement indicated drs anil potti marvaretta stevenson take full responsibility error published journal chest paper retracted retraction notice stating authors relied results reported potti aware errors subsequently httpsenwikipediaorgwikianilpotti